Published in Sex Weekly Plus, November 10th, 1997
Researchers seeking to develop a genital herpes vaccine face conflicting data on the correlates of immunity, a sense that a two-vaccine approach may be needed, and, after a failed clinical trial, fears that a successful vaccine may be impossible: a litany well-known to those trying to develop an AIDS vaccine.
"Where we are with the development of HSV vaccines is that empiricism has led us mainly to the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Sex Weekly Plus
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.